Physician profile
Samantha Walker
NPI 1396426086
$941.11
in general payments reported to CMS, 2019-2025
11 companies · $192 in 2025
The $192 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $365 · 2024: $384 · 2025: $192.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $804 · Education: $137.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $804.10 |
| Education | $137.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $255.99 | 2023-2025 | Otezla, Otezla, Repatha |
| Medical Device Business Services, INC. | $137.01 | 2024 | |
| Incyte Corporation | $115.93 | 2023 | Opzelura |
| Ethicon US, LLC | $104.28 | 2024 | Stratafix |
| Bayer Healthcare Pharmaceuticals INC. | $74.09 | 2024-2025 | |
| Lilly USA, LLC | $56.94 | 2024-2025 | Mounjaro |
| Novo Nordisk INC | $53.00 | 2025 | Ozempic |
| Abbvie INC. | $50.78 | 2023 | |
| Astellas Pharma US INC | $40.89 | 2025 | Veozah |
| Regeneron Healthcare Solutions, INC. | $30.85 | 2023 | Dupixent |
| Kerecis Limited | $21.35 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Samantha Walker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.